![]() |
|
|
Vol. 19, Issue 10, 4434-4441, October 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



*Institut für Pharmakologie und Toxikologie, Technischen Universiät München, D-80802 München, Germany;
ZAUM-Zentrum Allergie und Umwelt, KKG-UDA, Helmholtzzentrum München/TUM, D-80802 München, Germany;
Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten der Ludwig-Maximilians-Universität München, D-80336 München, Germany;
Sektion für Medizinische Biochemie, Medizinische Universität Innsbruck, A-6020 Innsbruck, Austria; and ||Interfakultäres Institut für Biochemie, Universität Tübingen, D-72076 Tübingen, Germany
Submitted April 9, 2008;
Revised July 22, 2008;
Accepted July 30, 2008
Monitoring Editor: Sandra L. Schmid
The cyclic guanosine monophosphate (cGMP)/cGMP-dependent protein kinase type I (cGKI) pathway regulates many cellular functions. The current study shows that 8-Br-cGMP stimulates the number of attached primary but not that of subcultured murine vascular smooth muscle cells (VSMCs). These effects of 8-Br-cGMP require the presence of cGKI. In agreement with previous studies, cGKI inhibited the number of cells in repeatedly passaged murine VSMCs. Activation of the cGMP/cGKI pathway in freshly isolated primary VSMCs slightly decreased apoptosis and strongly increased cell adhesion. The stimulation of cell adhesion by cGKI involves an inhibition of the RhoA/Rho kinase pathway and increased exposure of β1 and β3 integrins on the cell surface. Together, these results identify a novel proadhesive function of cGMP/cGKI signaling in primary VSMCs and suggest that the opposing effects of this pathway on VSMC number depend on the phenotypic context of the cells.
Address correspondence to: Pascal Weinmeister (weinmeister{at}ipt.med.tu-muenchen.de)
Abbreviations used: cAK, cAMP-dependent protein kinase; cGKI, cGMP-dependent protein kinase type I; VSMC, vascular smooth muscle cell.
This article has been cited by other articles:
![]() |
N. Valtcheva, P. Nestorov, A. Beck, M. Russwurm, M. Hillenbrand, P. Weinmeister, and R. Feil The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells J. Biol. Chem., January 2, 2009; 284(1): 556 - 562. [Abstract] [Full Text] [PDF] |
||||